Loss-Making Fortress Biotech, Inc. (NASDAQ:FBIO) Expected To Breakeven

Fortress Biotech, Inc.'s (NASDAQ:FBIO): Fortress Biotech, Inc. develops and commercializes pharmaceutical and…